Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 reinfection and implications for vaccine development
Firzan Nainu, Rufika S. Abidin, Muh. Akbar Bahar, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 3061-3073
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study
Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2210-2210
Open Access | Times Cited: 91
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review
Andri Frediansyah
Clinical Epidemiology and Global Health (2021) Vol. 12, pp. 100826-100826
Open Access | Times Cited: 63
Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis
Fauzi Yusuf, Marhami Fahriani, Sukamto S. Mamada, et al.
F1000Research (2021) Vol. 10, pp. 301-301
Open Access | Times Cited: 53
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 50
Cross‐reactivity of SARS‐CoV‐2 with other pathogens, especially dengue virus: A historical perspective
Debrupa Dutta, A. C. Ghosh, Chiroshri Dutta, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 16
Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 36
Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4305-4305
Open Access | Times Cited: 24
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Possibility of exosome‑based coronavirus disease 2019 vaccine (Review)
Kwang Ho Yoo, Nikita Thapa, Beom Joon Kim, et al.
Molecular Medicine Reports (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 28
The medicinal value of tea drinking in the management of COVID-19
Jiaming Ge, Tianbao Song, Mengyuan Li, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e12968-e12968
Open Access | Times Cited: 11
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
SARS-CoV-2 herd immunity of the Kyrgyz population in 2021
Anna Y. Popova, Omor T. Kasymov, Vyacheslav Y. Smolenski, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 4, pp. 195-210
Open Access | Times Cited: 18
Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment
Ishani Chakrabartty, Maryam Khan, Saurov Mahanta, et al.
Annals of Medicine and Surgery (2022) Vol. 79
Open Access | Times Cited: 17
Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
Jialu Huang, Yubo Ding, Jingwei Yao, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 405-405
Open Access | Times Cited: 16
Modern drug discovery applications for the identification of novel candidates for COVID-19 infections
Isha Rani, Avjit Kalsi, Gagandeep Kaur, et al.
Annals of Medicine and Surgery (2022) Vol. 80
Open Access | Times Cited: 16
Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020
Maureen Rebecca Smith, Maria Trofimova, Ariane Weber, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Breakthrough SARS-CoV-2 infections after COVID-19 immunization
Joshua Hirsh, Thwe Htay, Shubhang Bhalla, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 6, pp. 1429-1432
Open Access | Times Cited: 14
Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies
Jingwen Liu, Xiao Jun Huang, Mingke Wang, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 8, pp. 1663-1671
Open Access | Times Cited: 2
Role of natural products towards the SARS-CoV-2: A critical review
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
Annals of Medicine and Surgery (2022) Vol. 80
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top